×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Chinook Therapeutics Inc. (KDNY) NASDAQ

$40.39 - (-)

Market Cap: -

As of 08/10/23 12:00 AM EDT. Market closed.

(KDNY)

Chinook Therapeutics Inc. (KDNY)
NASDAQ

$40.39
- (-)

Market Cap: -

As of 08/10/23 12:00 AM EDT. Market closed.

Add to Portfolio

chinook therapeutics (nasdaq: kdny) is a clinical-stage biotechnology company developing precision medicines for kidney diseases. kidney diseases are a severe and growing problem worldwide, with a lack of effective treatments often leading to dialysis, transplantation and high costs to health care systems. drug development in kidney diseases is experiencing a resurgence due to greater ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
740 Heinz Ave, California, Berkeley, 94710-2748.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Stephen Isaacs
Address
740 Heinz Ave, California, Berkeley, 94710-2748.
PRICE CHART FOR CHINOOK THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$40.39
Days Range
$40.30 - $40.51
52 week range
- - -
Volume
4,924,994
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
71,804,977
Open
-
Previous Close
$40.39
Days Range
$40.30 - $40.51
52 week range
- - -
Volume
4,924,994
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
71,804,977
FINANCIAL STATEMENTS FOR CHINOOK THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CHINOOK THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
King Andrew JamesChief Scientific OfficerAug 01, 2023 Sale$39.031,16845,58619,157Aug 01, 2023, 07:27 PM
Greenman William MarinerDirectorMay 30, 2023 Sale$23.301,15526,91123,643May 31, 2023, 07:26 PM
DOBMEIER ERICPresident, CEOApr 24, 2023 Option Exercise$0.4225,00010,500326,138Apr 26, 2023, 05:19 PM
DOBMEIER ERICPresident, CEOApr 24, 2023 Sale$21.6125,000540,239302,338Apr 26, 2023, 05:19 PM
Jerel DavisDirectorApr 17, 2023 Sale$20.75295,8086,138,223443,713Apr 19, 2023, 05:58 PM
King Andrew JamesChief Scientific OfficerApr 03, 2023 Option Exercise$0.352,50087521,992Apr 05, 2023, 04:43 PM
King Andrew JamesChief Scientific OfficerApr 03, 2023 Sale$23.345,000116,71816,992Apr 05, 2023, 04:43 PM
Krishnan MaheshDirectorApr 04, 2023 Sale$23.0192421,2611,275Apr 04, 2023, 09:14 PM
Jerel DavisDirectorMar 01, 2023 Sale$22.75400,0009,100,0002,105,107Mar 03, 2023, 04:13 PM
BJERKHOLT ERICChief Financial OfficerFeb 10, 2023 Sale$23.7585720,35238,867Feb 15, 2023, 04:41 PM
DOBMEIER ERICPresident, CEOFeb 10, 2023 Sale$23.758,097192,292301,138Feb 15, 2023, 04:40 PM
Frohlich TomChief Operating OfficerFeb 10, 2023 Sale$23.753,70087,869150,777Feb 15, 2023, 04:40 PM
King Andrew JamesChief Scientific OfficerFeb 10, 2023 Sale$23.752,39256,80619,492Feb 15, 2023, 04:39 PM
Frohlich TomChief Operating OfficerJan 31, 2023 Sale$24.684,566112,700147,674Feb 02, 2023, 06:15 PM
BJERKHOLT ERICChief Financial OfficerJan 31, 2023 Sale$24.682,89171,35737,289Feb 02, 2023, 06:14 PM
King Andrew JamesChief Scientific OfficerJan 31, 2023 Sale$24.683,24480,06915,081Feb 02, 2023, 06:13 PM
DOBMEIER ERICPresident, CEOJan 30, 2023 Option Exercise$0.4225,00010,500296,676Feb 01, 2023, 08:32 PM
DOBMEIER ERICPresident, CEOJan 31, 2023 Sale$24.687,688189,757288,987Feb 01, 2023, 08:32 PM
DOBMEIER ERICPresident, CEOJan 30, 2023 Sale$24.5425,000613,613271,676Feb 01, 2023, 08:32 PM
King Andrew JamesChief Scientific OfficerJan 03, 2023 Option Exercise$0.357,5002,62519,992Jan 04, 2023, 07:44 PM
King Andrew JamesChief Scientific OfficerJan 03, 2023 Sale$25.8210,000258,1839,992Jan 04, 2023, 07:44 PM
Frohlich TomChief Operating OfficerDec 13, 2022 Option Exercise$0.4210,0004,200153,907Dec 15, 2022, 04:28 PM
Frohlich TomChief Operating OfficerDec 13, 2022 Sale$25.0010,000250,005143,907Dec 15, 2022, 04:28 PM
DOBMEIER ERICPresident, CEODec 14, 2022 Option Exercise$0.3530,00010,500271,676Dec 15, 2022, 04:27 PM
DOBMEIER ERICPresident, CEODec 01, 2022 Option Exercise$0.4260,00025,200271,676Dec 02, 2022, 04:26 PM
DOBMEIER ERICPresident, CEODec 01, 2022 Sale$22.3130,000669,351241,676Dec 02, 2022, 04:26 PM
BJERKHOLT ERICChief Financial OfficerDec 01, 2022 Sale$22.295,770128,60232,847Dec 02, 2022, 04:25 PM
Frohlich TomChief Operating OfficerNov 07, 2022 Option Exercise$0.4210,0004,200153,907Nov 09, 2022, 04:21 PM
Frohlich TomChief Operating OfficerNov 07, 2022 Sale$22.1610,000221,642143,907Nov 09, 2022, 04:21 PM
Frohlich TomChief Operating OfficerOct 06, 2022 Sale$19.697,360144,933143,907Oct 11, 2022, 04:33 PM
King Andrew JamesChief Scientific OfficerOct 06, 2022 Sale$19.693,55770,04412,492Oct 11, 2022, 04:32 PM
Thomas DolcaDirectorSep 02, 2022 Buy$21.2210,000212,19410,000Sep 06, 2022, 04:35 PM
King Andrew JamesChief Scientific OfficerAug 04, 2022 Option Exercise$0.355,0001,75010,897Aug 05, 2022, 05:09 PM
King Andrew JamesChief Scientific OfficerAug 04, 2022 Sale$20.005,000100,0005,897Aug 05, 2022, 05:09 PM
King Andrew JamesChief Scientific OfficerJul 11, 2022 Option Exercise$0.355,0001,75010,897Jul 13, 2022, 04:11 PM
King Andrew JamesChief Scientific OfficerJul 11, 2022 Sale$18.095,00090,4685,897Jul 13, 2022, 04:11 PM
AKKARAJU SRINIVASDirectorMay 27, 2022 Buy$14.00570,0007,980,0005,161,888Jun 01, 2022, 04:13 PM
DOBMEIER ERICPresident, CEOMay 25, 2022 Buy$13.035,00065,148205,880May 27, 2022, 06:17 PM
King Andrew JamesChief Scientific OfficerApr 11, 2022 Option Exercise$0.355,0001,75010,897Apr 13, 2022, 05:34 PM
King Andrew JamesChief Scientific OfficerApr 11, 2022 Sale$15.365,00076,8125,897Apr 13, 2022, 05:34 PM
King Andrew JamesChief Scientific OfficerFeb 18, 2022 Sale$13.002,50032,5005,897Feb 23, 2022, 05:17 PM
BJERKHOLT ERICChief Financial OfficerFeb 11, 2022 Sale$12.7489511,40322,203Feb 14, 2022, 07:58 PM
King Andrew JamesChief Scientific OfficerFeb 11, 2022 Sale$12.742,49831,8278,397Feb 14, 2022, 07:56 PM
Glicklich AlanChief Medical OfficerFeb 11, 2022 Sale$12.742,39130,4647,891Feb 14, 2022, 07:56 PM
Frohlich TomChief Operating OfficerFeb 11, 2022 Sale$12.743,73547,587137,685Feb 14, 2022, 07:53 PM
King Andrew JamesChief Scientific OfficerFeb 10, 2022 Option Exercise$0.352,5008756,594Feb 11, 2022, 05:26 PM
King Andrew JamesChief Scientific OfficerFeb 10, 2022 Sale$13.312,50033,2754,094Feb 11, 2022, 05:26 PM
Versant Venture Capital VII, L.P.10% OwnerJan 03, 2022 Sale$16.00400,0006,400,0801,863,197Jan 05, 2022, 05:16 PM
Versant Venture Capital VII, L.P.10% OwnerJan 03, 2022 Sale$16.00600,0009,600,1203,623,023Jan 05, 2022, 05:16 PM
Jerel DavisDirectorJan 03, 2022 Sale$16.001,000,00016,000,2003,623,023Jan 05, 2022, 05:13 PM
DOBMEIER ERICPresident, CEODec 23, 2021 Option Exercise$0.3540,00014,000180,633Dec 27, 2021, 06:24 PM
BJERKHOLT ERICChief Financial OfficerDec 01, 2021 Option Exercise$16.025,75092,09720,664Dec 03, 2021, 07:05 PM
AKKARAJU SRINIVASDirectorNov 15, 2021 Buy$14.001,215,00017,010,0004,591,888Nov 17, 2021, 12:05 PM
Frohlich TomChief Operating OfficerNov 10, 2021 Sale$15.486,23096,440134,619Nov 12, 2021, 08:00 PM
King Andrew JamesChief Scientific OfficerNov 09, 2021 Option Exercise$0.352,5008759,094Nov 12, 2021, 07:59 PM
King Andrew JamesChief Scientific OfficerNov 09, 2021 Sale$13.535,00067,6604,094Nov 12, 2021, 07:59 PM
Frohlich TomChief Operating OfficerNov 05, 2021 Option Exercise$0.4215,0006,300174,619Nov 09, 2021, 09:40 PM
Frohlich TomChief Operating OfficerNov 08, 2021 Sale$15.1713,770208,938140,849Nov 09, 2021, 09:40 PM
Frohlich TomChief Operating OfficerNov 05, 2021 Sale$14.0020,000280,000159,619Nov 09, 2021, 09:40 PM
Greenman William MarinerDirectorOct 21, 2021 Option Exercise$2.601,6634,32421,498Oct 22, 2021, 06:47 PM
Frohlich TomChief Operating OfficerOct 06, 2021 Option Exercise$12.377,35991,021159,619Oct 08, 2021, 06:51 PM
King Andrew JamesChief Scientific OfficerOct 06, 2021 Option Exercise$12.373,55743,9956,594Oct 08, 2021, 06:48 PM
Glicklich AlanChief Medical OfficerOct 06, 2021 Option Exercise$12.372,48930,7854,614Oct 08, 2021, 06:46 PM
Frohlich TomChief Operating OfficerSep 24, 2021 Option Exercise$0.4220,0008,400153,398Sep 28, 2021, 04:46 PM
Frohlich TomChief Operating OfficerSep 24, 2021 Sale$13.0020,000260,000133,398Sep 24, 2021, 08:16 PM
DOBMEIER ERICPresident, CEOSep 20, 2021 Buy$12.002,00024,000109,837Sep 22, 2021, 07:23 PM
Jerel DavisDirectorAug 27, 2021 Sale$14.00850,00011,900,0004,223,023Aug 31, 2021, 07:06 PM
Versant Venture Capital VII, L.P.10% OwnerAug 27, 2021 Sale$14.00510,0007,140,0004,223,023Aug 31, 2021, 07:06 PM
Versant Venture Capital VII, L.P.10% OwnerAug 27, 2021 Sale$14.00340,0004,760,0002,171,197Aug 31, 2021, 07:06 PM
AKKARAJU SRINIVASDirectorAug 18, 2021 Buy$11.98208,5002,497,8303,376,888Aug 20, 2021, 05:37 PM
DOBMEIER ERICPresident, CEOAug 19, 2021 Buy$12.003,00036,000107,837Aug 19, 2021, 05:55 PM
DOBMEIER ERICPresident, CEOAug 18, 2021 Buy$11.747,00082,163104,837Aug 19, 2021, 05:55 PM
Glicklich AlanChief Medical OfficerJun 16, 2021 Option Exercise$0.4220,0008,40020,000Jun 17, 2021, 06:40 PM
Glicklich AlanChief Medical OfficerJun 16, 2021 Sale$16.3520,000326,9680Jun 17, 2021, 06:40 PM
DOBMEIER ERICPresident, CEOJun 14, 2021 Option Exercise$0.3520,0007,00097,837Jun 15, 2021, 05:24 PM
DOBMEIER ERICPresident, CEODec 21, 2020 Option Exercise$0.3520,0007,00076,837Dec 22, 2020, 07:47 PM
DOBMEIER ERICPresident, CEODec 09, 2020 Buy$13.072,00026,15056,837Dec 10, 2020, 05:38 PM
DOBMEIER ERICPresident, CEODec 08, 2020 Buy$13.242,00026,48354,837Dec 10, 2020, 05:38 PM
DOBMEIER ERICPresident, CEONov 23, 2020 Buy$13.6792912,69952,837Nov 23, 2020, 07:26 PM
DOBMEIER ERICPresident, CEONov 20, 2020 Buy$13.695717,81751,908Nov 23, 2020, 07:26 PM
DOBMEIER ERICPresident, CEONov 19, 2020 Buy$13.505006,75051,337Nov 23, 2020, 07:26 PM
DOBMEIER ERICPresident, CEONov 11, 2020 Buy$13.752,50034,37550,837Nov 13, 2020, 06:13 PM
DOBMEIER ERICPresident, CEONov 10, 2020 Buy$13.862,00027,72048,337Nov 13, 2020, 06:13 PM
ISAACS STEPHEN TPresident and CEOSep 15, 2020 Sale$2.3932,48177,691279,166Sep 17, 2020, 08:17 PM
Templeman BlaineChief Legal OfficerSep 15, 2020 Sale$2.3912,36929,585121,916Sep 17, 2020, 08:16 PM
Ferber CelesteSVP, GC and SecretarySep 15, 2020 Sale$2.392,3965,73138,687Sep 17, 2020, 08:15 PM
Nuyten Dimitry SAChief Medical OfficerAug 07, 2020 Sale$2.553,5389,0368,462Aug 11, 2020, 04:06 PM
Templeman BlaineChief Legal OfficerAug 07, 2020 Sale$2.557,95120,308134,285Aug 11, 2020, 04:05 PM
Ferber CelesteSVP, GC and SecretaryAug 07, 2020 Sale$2.557,95120,30841,083Aug 11, 2020, 04:04 PM
Greenman William MarinerDirectorMar 18, 2020 Option Exercise$0.4519,8358,92619,835Mar 20, 2020, 05:18 PM
ISAACS STEPHEN TPresident and CEOMar 18, 2020 Option Exercise$0.4521,6189,728311,647Mar 20, 2020, 05:17 PM
van Elsas AndreaChief Scientific OfficerFeb 25, 2020 Sale$3.516,82323,954438,367Feb 26, 2020, 06:58 PM
van Elsas AndreaChief Scientific OfficerJan 03, 2020 Sale$1.1973,31187,108445,190Jan 06, 2020, 06:38 PM
Templeman BlaineChief Legal OfficerDec 12, 2019 Sale$1.161,2641,470117,736Dec 16, 2019, 04:14 PM
Ferber CelesteSVP, GC and SecretaryDec 12, 2019 Sale$1.1640847526,534Dec 16, 2019, 04:13 PM
van Elsas AndreaChief Scientific OfficerDec 12, 2019 Sale$1.162,1922,550518,501Dec 16, 2019, 04:13 PM
ISAACS STEPHEN TPresident and CEODec 12, 2019 Sale$1.165,8976,860290,029Dec 16, 2019, 04:12 PM
Haghighat RossDirectorSep 16, 2019 Option Exercise$0.6455,53935,52787,122Sep 18, 2019, 07:00 PM
Ferber CelesteSVP, GC and SecretarySep 13, 2019 Sale$1.312,4943,25728,044Sep 17, 2019, 06:34 PM
ISAACS STEPHEN TPresident and CEOSep 13, 2019 Sale$1.3131,09840,608295,926Sep 17, 2019, 06:34 PM
van Elsas AndreaChief Scientific OfficerSep 13, 2019 Sale$1.3118,59324,279521,327Sep 17, 2019, 06:33 PM
Templeman BlaineChief Legal OfficerSep 13, 2019 Sale$1.3112,87816,817122,888Sep 17, 2019, 06:32 PM
Ferber CelesteSVP, GC and SecretaryMay 20, 2019 Sale$3.212,0006,41329,436May 22, 2019, 07:04 PM
Lew JenniferChief Financial OfficerMay 01, 2019 Option Exercise$1.2518,60223,306147,299May 03, 2019, 07:17 PM
Lew JenniferChief Financial OfficerMay 01, 2019 Sale$4.2018,60278,136135,155May 03, 2019, 07:17 PM
Lew JenniferChief Financial OfficerApr 08, 2019 Option Exercise$1.2518,60123,305147,299Apr 10, 2019, 07:09 PM
Lew JenniferChief Financial OfficerApr 08, 2019 Sale$4.0718,60175,775135,155Apr 10, 2019, 07:09 PM
van Elsas AndreaChief Scientific OfficerMar 19, 2019 Sale$3.966,08124,107239,557Mar 21, 2019, 05:35 PM
van Elsas AndreaChief Scientific OfficerFeb 26, 2019 Sale$4.256,84429,120245,638Feb 27, 2019, 07:07 PM
van Elsas AndreaChief Scientific OfficerDec 28, 2018 Sale$2.571,9074,901252,482Dec 31, 2018, 04:02 PM
Lew JenniferChief Financial OfficerDec 12, 2018 Sale$2.931,0353,035135,155Dec 14, 2018, 04:19 PM
Templeman BlaineChief Legal OfficerDec 12, 2018 Sale$2.931,2413,639129,878Dec 14, 2018, 04:18 PM
ISAACS STEPHEN TPresident and CEODec 12, 2018 Sale$2.935,82917,091327,024Dec 14, 2018, 04:17 PM
van Elsas AndreaChief Scientific OfficerDec 12, 2018 Sale$2.932,1716,365254,389Dec 14, 2018, 04:15 PM
Templeman BlaineChief Legal OfficerNov 20, 2018 Sale$2.918432,453131,119Nov 20, 2018, 07:58 PM
van Elsas AndreaChief Scientific OfficerSep 24, 2018 Sale$5.837,72645,022256,560Sep 25, 2018, 08:11 PM
Templeman BlaineChief Legal OfficerSep 24, 2018 Sale$5.8110,26259,613131,119Sep 25, 2018, 08:10 PM
Templeman BlaineExecutive VP, General CounselSep 13, 2018 Sale$6.506,05639,360141,381Sep 14, 2018, 07:29 PM
van Elsas AndreaChief Scientific OfficerSep 13, 2018 Sale$6.509,75463,394264,286Sep 14, 2018, 07:28 PM
Lew JenniferChief Financial OfficerSep 13, 2018 Sale$6.505,62336,546136,190Sep 14, 2018, 07:27 PM
Sacks NatalieChief Medical OfficerSep 13, 2018 Sale$6.503,02819,680173,720Sep 14, 2018, 07:25 PM
ISAACS STEPHEN TPresident and CEOSep 13, 2018 Sale$6.5024,143156,913332,853Sep 14, 2018, 07:24 PM
ISAACS STEPHEN TPresident and CEOSep 06, 2018 Option Exercise$1.0046,98746,987252,733Sep 06, 2018, 07:42 PM
ISAACS STEPHEN TPresident and CEOSep 05, 2018 Option Exercise$1.0015,58515,585221,331Sep 06, 2018, 07:42 PM
ISAACS STEPHEN TPresident and CEOSep 06, 2018 Sale$7.9246,987372,024205,746Sep 06, 2018, 07:42 PM
ISAACS STEPHEN TPresident and CEOSep 05, 2018 Sale$7.9015,585123,134205,746Sep 06, 2018, 07:42 PM
Sacks NatalieChief Medical OfficerSep 04, 2018 Sale$7.134,50432,09989,548Sep 06, 2018, 07:40 PM
van Elsas AndreaChief Scientific OfficerJul 17, 2018 Sale$6.9610,45472,803206,215Jul 19, 2018, 07:39 PM
ISAACS STEPHEN TPresident and CEOJun 01, 2018 Option Exercise$1.0040,00040,000245,746Jun 05, 2018, 08:58 PM
ISAACS STEPHEN TPresident and CEOJun 01, 2018 Sale$8.6840,000347,004205,746Jun 05, 2018, 08:58 PM
Templeman BlaineChief Legal OfficerMay 17, 2018 Sale$8.152,00016,30069,937May 21, 2018, 06:25 PM
ISAACS STEPHEN TPresident and CEOMay 09, 2018 Option Exercise$0.9740,00038,976245,746May 11, 2018, 05:00 PM
ISAACS STEPHEN TPresident and CEOMay 09, 2018 Sale$8.0140,000320,348205,746May 11, 2018, 05:00 PM
ISAACS STEPHEN TPresident and CEOApr 02, 2018 Option Exercise$0.8240,00032,800245,746Apr 04, 2018, 06:26 PM
ISAACS STEPHEN TPresident and CEOApr 02, 2018 Sale$8.9140,000356,400205,746Apr 04, 2018, 06:26 PM
ISAACS STEPHEN TPresident and CEOMar 09, 2018 Option Exercise$0.5046,41723,165252,163Mar 09, 2018, 07:40 PM
ISAACS STEPHEN TPresident and CEOMar 08, 2018 Option Exercise$0.4525,63411,535231,380Mar 09, 2018, 07:40 PM
ISAACS STEPHEN TPresident and CEOMar 09, 2018 Sale$8.7746,417407,268226,351Mar 09, 2018, 07:40 PM
ISAACS STEPHEN TPresident and CEOMar 08, 2018 Sale$7.9525,634203,790205,746Mar 09, 2018, 07:40 PM
van Elsas AndreaChief Scientific OfficerFeb 26, 2018 Sale$6.486,87444,522216,669Feb 27, 2018, 06:56 PM
SCHAFER GREGORY WChief Operating OfficerJan 25, 2018 Option Exercise$0.8260,00049,200250,745Jan 26, 2018, 07:15 PM
SCHAFER GREGORY WChief Operating OfficerJan 25, 2018 Option Exercise$0.013,31733254,062Jan 26, 2018, 07:15 PM
ISAACS STEPHEN TPresident and CEOJan 05, 2018 Option Exercise$0.457,9493,577213,695Jan 09, 2018, 05:48 PM
ISAACS STEPHEN TPresident and CEOJan 05, 2018 Sale$7.957,94963,195205,746Jan 09, 2018, 05:48 PM
Brockstedt Dirk G.EVP of Research and Dev.Dec 29, 2017 Option Exercise$1.4552,00075,400124,603Jan 03, 2018, 07:03 PM
SCHAFER GREGORY WChief Operating OfficerDec 29, 2017 Option Exercise$0.8242,00034,440190,745Jan 03, 2018, 06:59 PM
SCHAFER GREGORY WChief Operating OfficerJan 02, 2018 Option Exercise$1.0420,00020,767210,745Jan 03, 2018, 06:59 PM
SCHAFER GREGORY WChief Operating OfficerJan 02, 2018 Sale$7.6120,000152,142190,745Jan 03, 2018, 06:59 PM
Templeman BlaineExecutive VP, General CounselDec 18, 2017 Sale$8.252,88423,79369,937Dec 20, 2017, 06:52 PM
Brockstedt Dirk G.EVP of Research and Dev.Dec 15, 2017 Option Exercise$1.4564,10892,957137,826Dec 15, 2017, 08:02 PM
Brockstedt Dirk G.EVP of Research and Dev.Dec 15, 2017 Sale$8.1165,223529,18772,603Dec 15, 2017, 08:02 PM
van Elsas AndreaChief Scientific OfficerSep 13, 2017 Sale$10.994,92254,072202,581Dec 15, 2017, 07:58 PM
Brockstedt Dirk G.EVP of Research and Dev.Dec 01, 2017 Option Exercise$0.5210,0005,20083,718Dec 04, 2017, 07:59 PM
Brockstedt Dirk G.EVP of Research and Dev.Dec 01, 2017 Sale$9.4010,00093,99873,718Dec 04, 2017, 07:59 PM
Lew JenniferSr. Vice President of FinanceDec 01, 2017 Option Exercise$0.826,6005,41268,938Dec 04, 2017, 07:57 PM
Lew JenniferSr. Vice President of FinanceDec 01, 2017 Sale$9.466,60062,43362,338Dec 04, 2017, 07:57 PM
SCHAFER GREGORY WChief Operating OfficerDec 01, 2017 Option Exercise$1.0420,00020,767168,745Dec 04, 2017, 07:56 PM
SCHAFER GREGORY WChief Operating OfficerDec 01, 2017 Sale$9.3420,000186,882148,745Dec 04, 2017, 07:56 PM
ISAACS STEPHEN TPresident and CEODec 01, 2017 Option Exercise$0.4540,00018,000213,921Dec 04, 2017, 07:53 PM
ISAACS STEPHEN TPresident and CEODec 01, 2017 Sale$9.3840,000375,028173,921Dec 04, 2017, 07:53 PM
Templeman BlaineExecutive VP, General CounselNov 17, 2017 Sale$8.852432,15158,834Nov 17, 2017, 06:43 PM
Lew JenniferSr. Vice President of FinanceNov 15, 2017 Option Exercise$0.826,6005,41268,938Nov 17, 2017, 06:42 PM
Lew JenniferSr. Vice President of FinanceNov 15, 2017 Sale$8.956,60059,07062,338Nov 17, 2017, 06:42 PM
ISAACS STEPHEN TPresident and CEONov 10, 2017 Option Exercise$0.4516,4007,380190,321Nov 14, 2017, 06:20 PM
ISAACS STEPHEN TPresident and CEONov 13, 2017 Option Exercise$0.453,4001,530177,321Nov 14, 2017, 06:20 PM
ISAACS STEPHEN TPresident and CEONov 10, 2017 Sale$7.9616,400130,508173,921Nov 14, 2017, 06:20 PM
ISAACS STEPHEN TPresident and CEONov 13, 2017 Sale$8.003,40027,215173,921Nov 14, 2017, 06:20 PM
Brockstedt Dirk G.EVP of Research and Dev.Nov 13, 2017 Option Exercise$0.524,0622,11277,780Nov 14, 2017, 06:09 PM
Brockstedt Dirk G.EVP of Research and Dev.Nov 10, 2017 Option Exercise$0.521,81594475,533Nov 14, 2017, 06:09 PM
Brockstedt Dirk G.EVP of Research and Dev.Nov 13, 2017 Sale$8.004,06232,49673,718Nov 14, 2017, 06:09 PM
Brockstedt Dirk G.EVP of Research and Dev.Nov 10, 2017 Sale$8.011,81514,54473,718Nov 14, 2017, 06:09 PM
SCHAFER GREGORY WChief Operating OfficerNov 06, 2017 Option Exercise$1.0420,00020,767168,745Nov 08, 2017, 08:01 PM
SCHAFER GREGORY WChief Operating OfficerNov 06, 2017 Sale$7.9720,000159,312148,745Nov 08, 2017, 08:01 PM
Brockstedt Dirk G.EVP of Research and Dev.Nov 06, 2017 Option Exercise$0.524,1232,14477,841Nov 08, 2017, 07:59 PM
Brockstedt Dirk G.EVP of Research and Dev.Nov 06, 2017 Sale$8.044,12333,13273,718Nov 08, 2017, 07:59 PM
ISAACS STEPHEN TPresident and CEONov 06, 2017 Option Exercise$0.4516,4007,380190,321Nov 08, 2017, 07:56 PM
ISAACS STEPHEN TPresident and CEONov 07, 2017 Option Exercise$0.453,8001,710177,721Nov 08, 2017, 07:56 PM
ISAACS STEPHEN TPresident and CEONov 07, 2017 Sale$7.953,80030,223173,921Nov 08, 2017, 07:56 PM
ISAACS STEPHEN TPresident and CEONov 06, 2017 Sale$7.9816,400130,934173,921Nov 08, 2017, 07:56 PM
Brockstedt Dirk G.EVP of Research and Dev.Oct 02, 2017 Option Exercise$0.5210,0005,20083,718Oct 04, 2017, 08:31 PM
Brockstedt Dirk G.EVP of Research and Dev.Oct 02, 2017 Sale$10.5910,000105,87073,718Oct 04, 2017, 08:31 PM
SCHAFER GREGORY WChief Operating OfficerOct 02, 2017 Option Exercise$1.3620,00027,148168,745Oct 04, 2017, 08:26 PM
SCHAFER GREGORY WChief Operating OfficerOct 02, 2017 Sale$10.7520,000215,060148,745Oct 04, 2017, 08:26 PM
ISAACS STEPHEN TPresident and CEOOct 02, 2017 Option Exercise$0.4540,00018,000213,921Oct 04, 2017, 08:23 PM
ISAACS STEPHEN TPresident and CEOOct 02, 2017 Sale$10.7840,000431,032173,921Oct 04, 2017, 08:23 PM
Lew JenniferSr. Vice President of FinanceOct 02, 2017 Option Exercise$0.826,6005,41268,938Oct 04, 2017, 08:21 PM
Lew JenniferSr. Vice President of FinanceOct 02, 2017 Sale$10.616,60069,99562,338Oct 04, 2017, 08:21 PM
Templeman BlaineExecutive VP, General CounselSep 18, 2017 Sale$11.202,88432,30158,834Sep 20, 2017, 07:11 PM
ISAACS STEPHEN TPresident and CEOSep 13, 2017 Sale$10.9912,204134,071173,921Sep 14, 2017, 09:25 PM
SCHAFER GREGORY WChief Operating OfficerSep 13, 2017 Sale$10.994,85953,380148,745Sep 14, 2017, 09:24 PM
Brockstedt Dirk G.EVP of Research and Dev.Sep 13, 2017 Sale$10.993,55739,07673,718Sep 14, 2017, 09:22 PM
Lew JenniferSr. Vice President of FinanceSep 13, 2017 Sale$10.993,55739,07662,338Sep 14, 2017, 09:21 PM
van Elsas AndreaChief Scientific OfficerSep 13, 2017 Sale$10.994,92254,072207,231Sep 14, 2017, 09:20 PM
Templeman BlaineExecutive VP, General CounselSep 13, 2017 Sale$10.993,55739,07661,718Sep 14, 2017, 09:19 PM
Sacks NatalieChief Medical OfficerSep 01, 2017 Sale$11.714,88557,19645,115Sep 06, 2017, 04:32 PM
SCHAFER GREGORY WChief Operating OfficerSep 01, 2017 Option Exercise$1.2420,00024,800140,979Sep 06, 2017, 04:30 PM
SCHAFER GREGORY WChief Operating OfficerSep 01, 2017 Sale$11.7020,000233,980120,979Sep 06, 2017, 04:30 PM
Lew JenniferSr. Vice President of FinanceSep 01, 2017 Option Exercise$0.826,6005,41249,195Sep 06, 2017, 04:29 PM
Lew JenniferSr. Vice President of FinanceSep 01, 2017 Sale$11.706,60077,24242,595Sep 06, 2017, 04:29 PM
ISAACS STEPHEN TPresident and CEOSep 01, 2017 Option Exercise$0.4540,00018,000144,025Sep 06, 2017, 04:28 PM
ISAACS STEPHEN TPresident and CEOSep 01, 2017 Sale$11.7140,000468,596104,025Sep 06, 2017, 04:28 PM
Brockstedt Dirk G.EVP of Research and Dev.Sep 01, 2017 Option Exercise$0.5210,0005,20059,300Sep 06, 2017, 04:27 PM
Brockstedt Dirk G.EVP of Research and Dev.Sep 01, 2017 Sale$11.6910,000116,94849,300Sep 06, 2017, 04:27 PM
Dubensky Thomas W.Chief Scientific OfficerAug 11, 2017 Option Exercise$1.009,0889,08848,988Aug 11, 2017, 08:03 PM
Dubensky Thomas W.Chief Scientific OfficerAug 10, 2017 Option Exercise$1.0040,91240,91280,812Aug 11, 2017, 08:03 PM
Dubensky Thomas W.Chief Scientific OfficerAug 10, 2017 Sale$11.4340,912467,66539,900Aug 11, 2017, 08:03 PM
Dubensky Thomas W.Chief Scientific OfficerAug 11, 2017 Sale$11.179,088101,53839,900Aug 11, 2017, 08:03 PM
ISAACS STEPHEN TPresident and CEOAug 07, 2017 Option Exercise$0.4540,00018,000144,025Aug 09, 2017, 07:46 PM
ISAACS STEPHEN TPresident and CEOAug 07, 2017 Sale$12.1940,000487,564104,025Aug 09, 2017, 07:46 PM
SCHAFER GREGORY WChief Operating OfficerAug 08, 2017 Option Exercise$1.2714,18918,004135,168Aug 09, 2017, 07:45 PM
SCHAFER GREGORY WChief Operating OfficerAug 07, 2017 Option Exercise$1.2225,81131,616146,790Aug 09, 2017, 07:45 PM
SCHAFER GREGORY WChief Operating OfficerAug 07, 2017 Sale$12.1725,811314,233120,979Aug 09, 2017, 07:45 PM
SCHAFER GREGORY WChief Operating OfficerAug 08, 2017 Sale$12.1614,189172,550120,979Aug 09, 2017, 07:45 PM
Brockstedt Dirk G.EVP of Research and Dev.Aug 07, 2017 Option Exercise$0.5210,0005,20059,300Aug 09, 2017, 07:44 PM
Brockstedt Dirk G.EVP of Research and Dev.Aug 07, 2017 Sale$12.1810,000121,79549,300Aug 09, 2017, 07:44 PM
Lew JenniferSr. Vice President of FinanceAug 07, 2017 Option Exercise$0.826,6005,41249,195Aug 09, 2017, 07:41 PM
Lew JenniferSr. Vice President of FinanceAug 07, 2017 Sale$12.176,60080,29042,595Aug 09, 2017, 07:41 PM
Lew JenniferSr. Vice President of FinanceJul 03, 2017 Option Exercise$0.8212,0009,84054,595Jul 06, 2017, 07:13 PM
Lew JenniferSr. Vice President of FinanceJul 03, 2017 Sale$11.1412,000133,63242,595Jul 06, 2017, 07:13 PM
ISAACS STEPHEN TPresident and CEOJul 03, 2017 Option Exercise$0.5040,00019,965144,025Jul 06, 2017, 07:12 PM
ISAACS STEPHEN TPresident and CEOJul 05, 2017 Sale$11.011,34114,763104,025Jul 06, 2017, 07:12 PM
ISAACS STEPHEN TPresident and CEOJul 03, 2017 Sale$11.0638,659427,634105,366Jul 06, 2017, 07:12 PM
Brockstedt Dirk G.EVP of Research and Dev.Jul 03, 2017 Option Exercise$0.4810,0004,82659,300Jul 06, 2017, 07:11 PM
Brockstedt Dirk G.EVP of Research and Dev.Jul 03, 2017 Sale$11.0210,000110,16749,300Jul 06, 2017, 07:11 PM
Dubensky Thomas W.Chief Scientific OfficerJul 06, 2017 Option Exercise$0.524,5122,34644,412Jul 06, 2017, 07:10 PM
Dubensky Thomas W.Chief Scientific OfficerJul 05, 2017 Option Exercise$0.5233,68817,51873,588Jul 06, 2017, 07:10 PM
Dubensky Thomas W.Chief Scientific OfficerJul 03, 2017 Option Exercise$0.5211,8006,13651,700Jul 06, 2017, 07:10 PM
Dubensky Thomas W.Chief Scientific OfficerJul 06, 2017 Sale$11.234,51250,67339,900Jul 06, 2017, 07:10 PM
Dubensky Thomas W.Chief Scientific OfficerJul 05, 2017 Sale$11.4633,688385,93639,900Jul 06, 2017, 07:10 PM
Dubensky Thomas W.Chief Scientific OfficerJul 03, 2017 Sale$11.0211,800130,02839,900Jul 06, 2017, 07:10 PM
Lew JenniferSr. Vice President of FinanceJun 28, 2017 Option Exercise$0.8212,0009,84054,595Jun 30, 2017, 06:03 PM
Lew JenniferSr. Vice President of FinanceJun 28, 2017 Sale$11.1912,000134,23642,595Jun 30, 2017, 06:03 PM
SCHAFER GREGORY WChief Operating OfficerJun 28, 2017 Option Exercise$1.4540,00058,000160,979Jun 30, 2017, 06:01 PM
SCHAFER GREGORY WChief Operating OfficerJun 28, 2017 Sale$11.2640,000450,568120,979Jun 30, 2017, 06:01 PM
ISAACS STEPHEN TPresident and CEOJun 19, 2017 Option Exercise$0.5240,00020,800144,025Jun 21, 2017, 06:56 PM
ISAACS STEPHEN TPresident and CEOJun 19, 2017 Sale$10.5040,000420,164104,025Jun 21, 2017, 06:56 PM
Dubensky Thomas W.Chief Scientific OfficerJun 01, 2017 Option Exercise$0.5277,97140,545117,871Jun 05, 2017, 07:25 PM
Dubensky Thomas W.Chief Scientific OfficerJun 05, 2017 Option Exercise$0.5217,5779,14057,477Jun 05, 2017, 07:25 PM
Dubensky Thomas W.Chief Scientific OfficerJun 02, 2017 Option Exercise$0.5248,75325,35288,653Jun 05, 2017, 07:25 PM
Dubensky Thomas W.Chief Scientific OfficerJun 05, 2017 Sale$9.9917,577175,62839,900Jun 05, 2017, 07:25 PM
Dubensky Thomas W.Chief Scientific OfficerJun 02, 2017 Sale$10.1048,753492,28339,900Jun 05, 2017, 07:25 PM
Dubensky Thomas W.Chief Scientific OfficerJun 01, 2017 Sale$10.0077,971779,86639,900Jun 05, 2017, 07:25 PM
Brockstedt Dirk G.EVP of Research and Dev.Jun 01, 2017 Option Exercise$0.528,0004,16057,300Jun 05, 2017, 07:22 PM
Brockstedt Dirk G.EVP of Research and Dev.Jun 01, 2017 Sale$10.008,00080,02049,300Jun 05, 2017, 07:22 PM
Brockstedt Dirk G.EVP of Research and Dev.May 17, 2017 Sale$9.651,0119,75649,300May 18, 2017, 08:33 PM
Templeman BlaineExecutive VP, General CounselMay 17, 2017 Sale$9.651,64815,90337,300May 18, 2017, 08:30 PM
ISAACS STEPHEN TPresident and CEOMay 15, 2017 Option Exercise$0.5210,6005,512114,625May 17, 2017, 05:55 PM
ISAACS STEPHEN TPresident and CEOMay 16, 2017 Option Exercise$0.5216,6738,670120,698May 17, 2017, 05:55 PM
ISAACS STEPHEN TPresident and CEOMay 16, 2017 Sale$10.0016,673166,797104,025May 17, 2017, 05:55 PM
ISAACS STEPHEN TPresident and CEOMay 15, 2017 Sale$10.0110,600106,154104,025May 17, 2017, 05:55 PM
Brockstedt Dirk G.EVP of Research and Dev.May 11, 2017 Option Exercise$0.528,0004,16057,300May 15, 2017, 06:57 PM
Brockstedt Dirk G.EVP of Research and Dev.May 11, 2017 Sale$9.728,00077,72549,300May 15, 2017, 06:57 PM
Dubensky Thomas W.Chief Scientific OfficerMay 12, 2017 Option Exercise$0.524,2992,23544,199May 15, 2017, 06:56 PM
Dubensky Thomas W.Chief Scientific OfficerMay 11, 2017 Option Exercise$0.521,40072841,300May 15, 2017, 06:56 PM
Dubensky Thomas W.Chief Scientific OfficerMay 12, 2017 Sale$9.924,29942,65839,900May 15, 2017, 06:56 PM
Dubensky Thomas W.Chief Scientific OfficerMay 11, 2017 Sale$9.911,40013,87039,900May 15, 2017, 06:56 PM
Brockstedt Dirk G.EVP of Research and Dev.Apr 03, 2017 Option Exercise$0.458,0003,60057,300Apr 04, 2017, 08:18 PM
Brockstedt Dirk G.EVP of Research and Dev.Apr 03, 2017 Sale$10.718,00085,64549,300Apr 04, 2017, 08:18 PM
ISAACS STEPHEN TPresident and CEOApr 03, 2017 Option Exercise$0.5227,27314,182129,473Apr 04, 2017, 08:17 PM
ISAACS STEPHEN TPresident and CEOApr 03, 2017 Sale$10.2827,273280,429102,200Apr 04, 2017, 08:17 PM
ISAACS STEPHEN TPresident and CEOMar 13, 2017 Option Exercise$0.5227,27314,182129,473Mar 14, 2017, 08:02 PM
ISAACS STEPHEN TPresident and CEOMar 13, 2017 Sale$11.3527,273309,434102,200Mar 14, 2017, 08:02 PM
Brockstedt Dirk G.EVP of Research and Dev.Mar 09, 2017 Option Exercise$0.458,0003,60057,300Mar 10, 2017, 08:05 PM
Brockstedt Dirk G.EVP of Research and Dev.Mar 09, 2017 Sale$11.008,00088,00149,300Mar 10, 2017, 08:05 PM
Dubensky Thomas W.Chief Scientific OfficerMar 09, 2017 Option Exercise$0.7825,00019,44664,900Mar 10, 2017, 08:04 PM
Dubensky Thomas W.Chief Scientific OfficerMar 09, 2017 Sale$10.9625,000274,07839,900Mar 10, 2017, 08:04 PM
Brockstedt Dirk G.EVP of Research and Dev.Jan 17, 2017 Option Exercise$0.458,0003,60057,300Jan 19, 2017, 06:52 PM
Brockstedt Dirk G.EVP of Research and Dev.Jan 17, 2017 Sale$11.868,00094,85849,300Jan 19, 2017, 06:52 PM
Templeman BlaineExecutive VP, General CounselJan 11, 2017 Sale$11.953,78545,23137,300Jan 13, 2017, 04:33 PM
Dubensky Thomas W.Chief Scientific OfficerJan 03, 2017 Option Exercise$0.5225,00013,00064,900Jan 05, 2017, 05:15 PM
Dubensky Thomas W.Chief Scientific OfficerJan 03, 2017 Sale$11.1625,000278,99039,900Jan 05, 2017, 05:15 PM
ISAACS STEPHEN TPresident and CEOJan 03, 2017 Option Exercise$0.5227,27314,182129,473Jan 05, 2017, 05:14 PM
ISAACS STEPHEN TPresident and CEOJan 03, 2017 Sale$11.1227,273303,289102,200Jan 05, 2017, 05:14 PM
SCHAFER GREGORY WChief Operating OfficerDec 23, 2016 Option Exercise$0.8235,00028,700120,979Dec 27, 2016, 09:12 AM
ISAACS STEPHEN TPresident and CEODec 01, 2016 Option Exercise$0.5227,27314,182129,473Dec 05, 2016, 07:23 PM
ISAACS STEPHEN TPresident and CEODec 01, 2016 Sale$10.8227,273295,169102,300Dec 05, 2016, 07:23 PM
Dubensky Thomas W.Chief Scientific OfficerDec 01, 2016 Option Exercise$1.0425,00025,89364,900Dec 05, 2016, 07:21 PM
Dubensky Thomas W.Chief Scientific OfficerDec 01, 2016 Sale$10.9425,000273,50039,900Dec 05, 2016, 07:21 PM
Haghighat RossDirectorNov 14, 2016 Sale$15.507,088109,86481,880Nov 16, 2016, 09:19 PM
ISAACS STEPHEN TPresident and CEONov 14, 2016 Option Exercise$0.5227,27314,182129,473Nov 16, 2016, 05:06 PM
ISAACS STEPHEN TPresident and CEONov 14, 2016 Sale$15.2627,273416,050102,200Nov 16, 2016, 05:06 PM
Lew JenniferSr. Vice President of FinanceNov 10, 2016 Option Exercise$0.8210,9108,94653,505Nov 14, 2016, 07:02 PM
Lew JenniferSr. Vice President of FinanceNov 10, 2016 Sale$14.9510,910163,10442,595Nov 14, 2016, 07:02 PM
SCHAFER GREGORY WChief Operating OfficerNov 11, 2016 Option Exercise$1.4530,14443,709116,123Nov 14, 2016, 07:01 PM
SCHAFER GREGORY WChief Operating OfficerNov 10, 2016 Option Exercise$1.4549,85672,291135,835Nov 14, 2016, 07:01 PM
SCHAFER GREGORY WChief Operating OfficerNov 11, 2016 Sale$14.8630,144448,03385,979Nov 14, 2016, 07:01 PM
SCHAFER GREGORY WChief Operating OfficerNov 10, 2016 Sale$14.7449,856734,69885,979Nov 14, 2016, 07:01 PM
Dubensky Thomas W.Chief Scientific OfficerNov 10, 2016 Option Exercise$1.3025,00032,58864,900Nov 14, 2016, 07:00 PM
Dubensky Thomas W.Chief Scientific OfficerNov 10, 2016 Sale$14.7825,000369,40839,900Nov 14, 2016, 07:00 PM
ISAACS STEPHEN TPresident and CEOOct 03, 2016 Option Exercise$0.5227,27314,182129,473Oct 05, 2016, 05:22 PM
ISAACS STEPHEN TPresident and CEOOct 03, 2016 Sale$12.6727,273345,522102,200Oct 05, 2016, 05:22 PM
Dubensky Thomas W.Chief Scientific OfficerOct 03, 2016 Option Exercise$1.1025,00027,43764,900Oct 05, 2016, 05:18 PM
Dubensky Thomas W.Chief Scientific OfficerOct 03, 2016 Sale$12.6825,000316,90839,900Oct 05, 2016, 05:18 PM
Lew JenniferSr. Vice President of FinanceSep 19, 2016 Option Exercise$0.825,4554,47348,955Sep 21, 2016, 04:57 PM
Lew JenniferSr. Vice President of FinanceSep 19, 2016 Sale$14.956,36095,08242,595Sep 21, 2016, 04:57 PM
Dubensky Thomas W.Chief Scientific OfficerSep 01, 2016 Option Exercise$1.1325,00028,25925,000Sep 02, 2016, 04:24 PM
Dubensky Thomas W.Chief Scientific OfficerSep 01, 2016 Sale$14.0325,000350,7750Sep 02, 2016, 04:24 PM
Dubensky Thomas W.Chief Scientific OfficerAug 11, 2016 Option Exercise$0.9925,00024,62525,000Aug 12, 2016, 05:43 PM
Dubensky Thomas W.Chief Scientific OfficerAug 11, 2016 Sale$15.1825,000379,5000Aug 12, 2016, 05:43 PM
Dubensky Thomas W.Chief Scientific OfficerJul 05, 2016 Option Exercise$1.0425,00025,96325,000Jul 07, 2016, 06:38 PM
Dubensky Thomas W.Chief Scientific OfficerJul 05, 2016 Sale$11.6125,000290,2500Jul 07, 2016, 06:38 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.May 16, 2016 Sale$8.209057,42112,000May 18, 2016, 07:14 PM
SCHAFER GREGORY WChief Operating OfficerMay 16, 2016 Sale$8.209057,42149,279May 18, 2016, 07:13 PM
Dubensky Thomas W.Chief Scientific OfficerMay 16, 2016 Sale$8.209057,4210May 18, 2016, 07:11 PM
Morningside Venture (VI) Investments Ltd10% OwnerFeb 18, 2016 Option Exercise$0.10762,01476,09719,805,532Feb 22, 2016, 05:59 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Jan 11, 2016 Option Exercise$0.4922,00010,85633,044Jan 11, 2016, 08:35 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Jan 11, 2016 Sale$21.7722,000479,01514,406Jan 11, 2016, 08:35 PM
SCHAFER GREGORY WChief Operating OfficerJan 08, 2016 Option Exercise$1.0020,00020,00069,279Jan 11, 2016, 08:33 PM
SCHAFER GREGORY WChief Operating OfficerJan 08, 2016 Sale$23.5820,000471,60049,279Jan 11, 2016, 08:33 PM
Dubensky Thomas W.Chief Scientific OfficerJan 04, 2016 Option Exercise$4.6815,00070,15815,000Jan 06, 2016, 06:18 PM
Dubensky Thomas W.Chief Scientific OfficerJan 04, 2016 Sale$26.3715,000395,5313,771Jan 06, 2016, 06:18 PM
ISAACS STEPHEN TPresident and CEOJan 05, 2016 Option Exercise$0.5212,5006,50022,500Jan 06, 2016, 06:16 PM
ISAACS STEPHEN TPresident and CEOJan 04, 2016 Option Exercise$0.5212,5006,50022,500Jan 06, 2016, 06:16 PM
ISAACS STEPHEN TPresident and CEOJan 04, 2016 Sale$26.3712,500329,60310,300Jan 06, 2016, 06:16 PM
ISAACS STEPHEN TPresident and CEOJan 05, 2016 Sale$26.2612,500328,19610,906Jan 06, 2016, 06:16 PM
Lew JenniferSr. Vice President of FinanceJan 06, 2016 Option Exercise$0.825,2424,29811,442Jan 06, 2016, 06:13 PM
Lew JenniferSr. Vice President of FinanceJan 06, 2016 Sale$25.715,242134,7657,000Jan 06, 2016, 06:13 PM
ISAACS STEPHEN TPresident and CEODec 31, 2015 Option Exercise$0.4510,0004,50010,000Jan 04, 2016, 07:04 PM
Lew JenniferSr. Vice President of FinanceDec 29, 2015 Option Exercise$0.824,2003,4446,200Dec 29, 2015, 06:11 PM
SCHAFER GREGORY WChief Operating OfficerDec 24, 2015 Option Exercise$0.8215,00012,30049,279Dec 28, 2015, 07:22 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Dec 16, 2015 Option Exercise$1.4512,00017,40012,000Dec 17, 2015, 07:06 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Dec 10, 2015 Option Exercise$1.4525,00036,25025,000Dec 14, 2015, 06:42 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Dec 10, 2015 Sale$29.8225,000745,42319,265Dec 14, 2015, 06:42 PM
SCHAFER GREGORY WChief Operating OfficerDec 07, 2015 Option Exercise$1.4525,00036,25059,279Dec 07, 2015, 07:40 PM
SCHAFER GREGORY WChief Operating OfficerDec 07, 2015 Sale$29.7425,000743,57142,579Dec 07, 2015, 07:40 PM
Lew JenniferSr. Vice President of FinanceDec 03, 2015 Option Exercise$0.825,2424,2987,242Dec 07, 2015, 07:32 PM
Lew JenniferSr. Vice President of FinanceDec 03, 2015 Sale$29.855,242156,4862,100Dec 07, 2015, 07:32 PM
ISAACS STEPHEN TPresident and CEODec 01, 2015 Option Exercise$0.5225,00013,00025,000Dec 02, 2015, 06:26 PM
ISAACS STEPHEN TPresident and CEODec 01, 2015 Sale$29.1125,000727,6642,200Dec 02, 2015, 06:26 PM
Dubensky Thomas W.Chief Scientific OfficerDec 01, 2015 Option Exercise$2.1530,00064,37330,000Dec 02, 2015, 06:24 PM
Dubensky Thomas W.Chief Scientific OfficerDec 01, 2015 Sale$29.2730,000878,1049,626Dec 02, 2015, 06:24 PM
Greenman William MarinerDirectorNov 30, 2015 Sale$30.653,00091,9500Dec 02, 2015, 06:21 PM
Lew JenniferSr. Vice President of FinanceNov 18, 2015 Option Exercise$0.825,2424,2988,712Nov 18, 2015, 08:30 PM
Lew JenniferSr. Vice President of FinanceNov 18, 2015 Sale$28.526,712191,4263,470Nov 18, 2015, 08:30 PM
ISAACS STEPHEN TPresident and CEONov 16, 2015 Option Exercise$0.5225,00013,00025,000Nov 18, 2015, 08:27 PM
ISAACS STEPHEN TPresident and CEONov 16, 2015 Sale$27.5425,000688,4902,700Nov 18, 2015, 08:27 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Nov 17, 2015 Option Exercise$0.6919,04713,22019,047Nov 18, 2015, 08:24 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Nov 16, 2015 Option Exercise$0.455,9532,6797,423Nov 18, 2015, 08:24 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Nov 17, 2015 Sale$28.6519,047545,73416,947Nov 18, 2015, 08:24 PM
Brockstedt Dirk G.Sr. VP of Research and Dev.Nov 16, 2015 Sale$27.527,423204,2941,470Nov 18, 2015, 08:24 PM
SCHAFER GREGORY WChief Operating OfficerNov 17, 2015 Option Exercise$1.4515,17822,00849,457Nov 18, 2015, 08:21 PM
SCHAFER GREGORY WChief Operating OfficerNov 16, 2015 Option Exercise$1.459,82214,24245,571Nov 18, 2015, 08:21 PM
SCHAFER GREGORY WChief Operating OfficerNov 17, 2015 Sale$28.6015,178434,07246,849Nov 18, 2015, 08:21 PM
SCHAFER GREGORY WChief Operating OfficerNov 16, 2015 Sale$27.5611,292311,16836,349Nov 18, 2015, 08:21 PM
Dubensky Thomas W.Chief Scientific OfficerNov 16, 2015 Option Exercise$1.459,48113,74710,951Nov 18, 2015, 08:11 PM
Dubensky Thomas W.Chief Scientific OfficerNov 17, 2015 Option Exercise$1.4520,51929,75320,519Nov 18, 2015, 08:11 PM
Dubensky Thomas W.Chief Scientific OfficerNov 16, 2015 Sale$27.5510,951301,7332,170Nov 18, 2015, 08:11 PM
Dubensky Thomas W.Chief Scientific OfficerNov 17, 2015 Sale$28.6520,519587,82218,520Nov 18, 2015, 08:11 PM
ISAACS STEPHEN TPresident and CEOJul 24, 2015 Option Exercise$0.0511,916609154,687Jul 27, 2015, 06:51 PM
Rogers John E. and Lois A.10% OwnerApr 20, 2015 Buy$17.007,500127,50033,649Apr 22, 2015, 05:50 PM
Rogers John E. and Lois A.10% OwnerApr 20, 2015 Buy$17.0010,000170,00036,149Apr 22, 2015, 05:50 PM
Rogers John E. and Lois A.10% OwnerApr 20, 2015 Buy$17.00147,0582,499,9865,991,759Apr 22, 2015, 05:49 PM
Morningside Venture (VI) Investments Ltd10% OwnerApr 20, 2015 Buy$17.00441,1767,499,99219,043,518Apr 22, 2015, 05:46 PM
OBrien Stephanie MonaghanDirectorApr 20, 2015 Buy$17.001,70028,9001,700Apr 22, 2015, 05:45 PM
OBrien Stephanie MonaghanDirectorApr 20, 2015 Buy$17.001,70028,9001,700Apr 22, 2015, 05:45 PM
Greenman William MarinerDirectorApr 20, 2015 Buy$17.003,00051,0003,000Apr 22, 2015, 05:43 PM
Lew JenniferSr. Vice President of FinanceApr 20, 2015 Buy$17.002,00034,0002,000Apr 22, 2015, 05:41 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
King Andrew JamesChief Scientific Officer08/01/202345,586
Greenman William MarinerDirector05/30/202326,911
DOBMEIER ERICPresident, CEO04/24/202310,500
DOBMEIER ERICPresident, CEO04/24/2023540,239
Jerel DavisDirector04/17/20236,138,223
King Andrew JamesChief Scientific Officer04/03/2023875
King Andrew JamesChief Scientific Officer04/03/2023116,718
Krishnan MaheshDirector04/04/202321,261
Jerel DavisDirector03/01/20239,100,000
BJERKHOLT ERICChief Financial Officer02/10/202320,352
DOBMEIER ERICPresident, CEO02/10/2023192,292
Frohlich TomChief Operating Officer02/10/202387,869
King Andrew JamesChief Scientific Officer02/10/202356,806
Frohlich TomChief Operating Officer01/31/2023112,700
BJERKHOLT ERICChief Financial Officer01/31/202371,357
King Andrew JamesChief Scientific Officer01/31/202380,069
DOBMEIER ERICPresident, CEO01/30/202310,500
DOBMEIER ERICPresident, CEO01/31/2023189,757
DOBMEIER ERICPresident, CEO01/30/2023613,613
King Andrew JamesChief Scientific Officer01/03/20232,625
King Andrew JamesChief Scientific Officer01/03/2023258,183
Frohlich TomChief Operating Officer12/13/20224,200
Frohlich TomChief Operating Officer12/13/2022250,005
DOBMEIER ERICPresident, CEO12/14/202210,500
DOBMEIER ERICPresident, CEO12/01/202225,200
DOBMEIER ERICPresident, CEO12/01/2022669,351
BJERKHOLT ERICChief Financial Officer12/01/2022128,602
Frohlich TomChief Operating Officer11/07/20224,200
Frohlich TomChief Operating Officer11/07/2022221,642
Frohlich TomChief Operating Officer10/06/2022144,933
King Andrew JamesChief Scientific Officer10/06/202270,044
Thomas DolcaDirector09/02/2022212,194
King Andrew JamesChief Scientific Officer08/04/20221,750
King Andrew JamesChief Scientific Officer08/04/2022100,000
King Andrew JamesChief Scientific Officer07/11/20221,750
King Andrew JamesChief Scientific Officer07/11/202290,468
AKKARAJU SRINIVASDirector05/27/20227,980,000
DOBMEIER ERICPresident, CEO05/25/202265,148
King Andrew JamesChief Scientific Officer04/11/20221,750
King Andrew JamesChief Scientific Officer04/11/202276,812
King Andrew JamesChief Scientific Officer02/18/202232,500
BJERKHOLT ERICChief Financial Officer02/11/202211,403
King Andrew JamesChief Scientific Officer02/11/202231,827
Glicklich AlanChief Medical Officer02/11/202230,464
Frohlich TomChief Operating Officer02/11/202247,587
King Andrew JamesChief Scientific Officer02/10/2022875
King Andrew JamesChief Scientific Officer02/10/202233,275
Versant Venture Capital VII, L.P.10% Owner01/03/20226,400,080
Versant Venture Capital VII, L.P.10% Owner01/03/20229,600,120
Jerel DavisDirector01/03/202216,000,200
DOBMEIER ERICPresident, CEO12/23/202114,000
BJERKHOLT ERICChief Financial Officer12/01/202192,097
AKKARAJU SRINIVASDirector11/15/202117,010,000
Frohlich TomChief Operating Officer11/10/202196,440
King Andrew JamesChief Scientific Officer11/09/2021875
King Andrew JamesChief Scientific Officer11/09/202167,660
Frohlich TomChief Operating Officer11/05/20216,300
Frohlich TomChief Operating Officer11/08/2021208,938
Frohlich TomChief Operating Officer11/05/2021280,000
Greenman William MarinerDirector10/21/20214,324
Frohlich TomChief Operating Officer10/06/202191,021
King Andrew JamesChief Scientific Officer10/06/202143,995
Glicklich AlanChief Medical Officer10/06/202130,785
Frohlich TomChief Operating Officer09/24/20218,400
Frohlich TomChief Operating Officer09/24/2021260,000
DOBMEIER ERICPresident, CEO09/20/202124,000
Jerel DavisDirector08/27/202111,900,000
Versant Venture Capital VII, L.P.10% Owner08/27/20217,140,000
Versant Venture Capital VII, L.P.10% Owner08/27/20214,760,000
AKKARAJU SRINIVASDirector08/18/20212,497,830
DOBMEIER ERICPresident, CEO08/19/202136,000
DOBMEIER ERICPresident, CEO08/18/202182,163
Glicklich AlanChief Medical Officer06/16/20218,400
Glicklich AlanChief Medical Officer06/16/2021326,968
DOBMEIER ERICPresident, CEO06/14/20217,000
DOBMEIER ERICPresident, CEO12/21/20207,000
DOBMEIER ERICPresident, CEO12/09/202026,150
DOBMEIER ERICPresident, CEO12/08/202026,483
DOBMEIER ERICPresident, CEO11/23/202012,699
DOBMEIER ERICPresident, CEO11/20/20207,817
DOBMEIER ERICPresident, CEO11/19/20206,750
DOBMEIER ERICPresident, CEO11/11/202034,375
DOBMEIER ERICPresident, CEO11/10/202027,720
ISAACS STEPHEN TPresident and CEO09/15/202077,691
Templeman BlaineChief Legal Officer09/15/202029,585
Ferber CelesteSVP, GC and Secretary09/15/20205,731
Nuyten Dimitry SAChief Medical Officer08/07/20209,036
Templeman BlaineChief Legal Officer08/07/202020,308
Ferber CelesteSVP, GC and Secretary08/07/202020,308
Greenman William MarinerDirector03/18/20208,926
ISAACS STEPHEN TPresident and CEO03/18/20209,728
van Elsas AndreaChief Scientific Officer02/25/202023,954
van Elsas AndreaChief Scientific Officer01/03/202087,108
Templeman BlaineChief Legal Officer12/12/20191,470
Ferber CelesteSVP, GC and Secretary12/12/2019475
van Elsas AndreaChief Scientific Officer12/12/20192,550
ISAACS STEPHEN TPresident and CEO12/12/20196,860
Haghighat RossDirector09/16/201935,527
Ferber CelesteSVP, GC and Secretary09/13/20193,257
ISAACS STEPHEN TPresident and CEO09/13/201940,608
van Elsas AndreaChief Scientific Officer09/13/201924,279
Templeman BlaineChief Legal Officer09/13/201916,817
Ferber CelesteSVP, GC and Secretary05/20/20196,413
Lew JenniferChief Financial Officer05/01/201923,306
Lew JenniferChief Financial Officer05/01/201978,136
Lew JenniferChief Financial Officer04/08/201923,305
Lew JenniferChief Financial Officer04/08/201975,775
van Elsas AndreaChief Scientific Officer03/19/201924,107
van Elsas AndreaChief Scientific Officer02/26/201929,120
van Elsas AndreaChief Scientific Officer12/28/20184,901
Lew JenniferChief Financial Officer12/12/20183,035
Templeman BlaineChief Legal Officer12/12/20183,639
ISAACS STEPHEN TPresident and CEO12/12/201817,091
van Elsas AndreaChief Scientific Officer12/12/20186,365
Templeman BlaineChief Legal Officer11/20/20182,453
van Elsas AndreaChief Scientific Officer09/24/201845,022
Templeman BlaineChief Legal Officer09/24/201859,613
Templeman BlaineExecutive VP, General Counsel09/13/201839,360
van Elsas AndreaChief Scientific Officer09/13/201863,394
Lew JenniferChief Financial Officer09/13/201836,546
Sacks NatalieChief Medical Officer09/13/201819,680
ISAACS STEPHEN TPresident and CEO09/13/2018156,913
ISAACS STEPHEN TPresident and CEO09/06/201846,987
ISAACS STEPHEN TPresident and CEO09/05/201815,585
ISAACS STEPHEN TPresident and CEO09/06/2018372,024
ISAACS STEPHEN TPresident and CEO09/05/2018123,134
Sacks NatalieChief Medical Officer09/04/201832,099
van Elsas AndreaChief Scientific Officer07/17/201872,803
ISAACS STEPHEN TPresident and CEO06/01/201840,000
ISAACS STEPHEN TPresident and CEO06/01/2018347,004
Templeman BlaineChief Legal Officer05/17/201816,300
ISAACS STEPHEN TPresident and CEO05/09/201838,976
ISAACS STEPHEN TPresident and CEO05/09/2018320,348
ISAACS STEPHEN TPresident and CEO04/02/201832,800
ISAACS STEPHEN TPresident and CEO04/02/2018356,400
ISAACS STEPHEN TPresident and CEO03/09/201823,165
ISAACS STEPHEN TPresident and CEO03/08/201811,535
ISAACS STEPHEN TPresident and CEO03/09/2018407,268
ISAACS STEPHEN TPresident and CEO03/08/2018203,790
van Elsas AndreaChief Scientific Officer02/26/201844,522
SCHAFER GREGORY WChief Operating Officer01/25/201849,200
SCHAFER GREGORY WChief Operating Officer01/25/201833
ISAACS STEPHEN TPresident and CEO01/05/20183,577
ISAACS STEPHEN TPresident and CEO01/05/201863,195
Brockstedt Dirk G.EVP of Research and Dev.12/29/201775,400
SCHAFER GREGORY WChief Operating Officer12/29/201734,440
SCHAFER GREGORY WChief Operating Officer01/02/201820,767
SCHAFER GREGORY WChief Operating Officer01/02/2018152,142
Templeman BlaineExecutive VP, General Counsel12/18/201723,793
Brockstedt Dirk G.EVP of Research and Dev.12/15/201792,957
Brockstedt Dirk G.EVP of Research and Dev.12/15/2017529,187
van Elsas AndreaChief Scientific Officer09/13/201754,072
Brockstedt Dirk G.EVP of Research and Dev.12/01/20175,200
Brockstedt Dirk G.EVP of Research and Dev.12/01/201793,998
Lew JenniferSr. Vice President of Finance12/01/20175,412
Lew JenniferSr. Vice President of Finance12/01/201762,433
SCHAFER GREGORY WChief Operating Officer12/01/201720,767
SCHAFER GREGORY WChief Operating Officer12/01/2017186,882
ISAACS STEPHEN TPresident and CEO12/01/201718,000
ISAACS STEPHEN TPresident and CEO12/01/2017375,028
Templeman BlaineExecutive VP, General Counsel11/17/20172,151
Lew JenniferSr. Vice President of Finance11/15/20175,412
Lew JenniferSr. Vice President of Finance11/15/201759,070
ISAACS STEPHEN TPresident and CEO11/10/20177,380
ISAACS STEPHEN TPresident and CEO11/13/20171,530
ISAACS STEPHEN TPresident and CEO11/10/2017130,508
ISAACS STEPHEN TPresident and CEO11/13/201727,215
Brockstedt Dirk G.EVP of Research and Dev.11/13/20172,112
Brockstedt Dirk G.EVP of Research and Dev.11/10/2017944
Brockstedt Dirk G.EVP of Research and Dev.11/13/201732,496
Brockstedt Dirk G.EVP of Research and Dev.11/10/201714,544
SCHAFER GREGORY WChief Operating Officer11/06/201720,767
SCHAFER GREGORY WChief Operating Officer11/06/2017159,312
Brockstedt Dirk G.EVP of Research and Dev.11/06/20172,144
Brockstedt Dirk G.EVP of Research and Dev.11/06/201733,132
ISAACS STEPHEN TPresident and CEO11/06/20177,380
ISAACS STEPHEN TPresident and CEO11/07/20171,710
ISAACS STEPHEN TPresident and CEO11/07/201730,223
ISAACS STEPHEN TPresident and CEO11/06/2017130,934
Brockstedt Dirk G.EVP of Research and Dev.10/02/20175,200
Brockstedt Dirk G.EVP of Research and Dev.10/02/2017105,870
SCHAFER GREGORY WChief Operating Officer10/02/201727,148
SCHAFER GREGORY WChief Operating Officer10/02/2017215,060
ISAACS STEPHEN TPresident and CEO10/02/201718,000
ISAACS STEPHEN TPresident and CEO10/02/2017431,032
Lew JenniferSr. Vice President of Finance10/02/20175,412
Lew JenniferSr. Vice President of Finance10/02/201769,995
Templeman BlaineExecutive VP, General Counsel09/18/201732,301
ISAACS STEPHEN TPresident and CEO09/13/2017134,071
SCHAFER GREGORY WChief Operating Officer09/13/201753,380
Brockstedt Dirk G.EVP of Research and Dev.09/13/201739,076
Lew JenniferSr. Vice President of Finance09/13/201739,076
van Elsas AndreaChief Scientific Officer09/13/201754,072
Templeman BlaineExecutive VP, General Counsel09/13/201739,076
Sacks NatalieChief Medical Officer09/01/201757,196
SCHAFER GREGORY WChief Operating Officer09/01/201724,800
SCHAFER GREGORY WChief Operating Officer09/01/2017233,980
Lew JenniferSr. Vice President of Finance09/01/20175,412
Lew JenniferSr. Vice President of Finance09/01/201777,242
ISAACS STEPHEN TPresident and CEO09/01/201718,000
ISAACS STEPHEN TPresident and CEO09/01/2017468,596
Brockstedt Dirk G.EVP of Research and Dev.09/01/20175,200
Brockstedt Dirk G.EVP of Research and Dev.09/01/2017116,948
Dubensky Thomas W.Chief Scientific Officer08/11/20179,088
Dubensky Thomas W.Chief Scientific Officer08/10/201740,912
Dubensky Thomas W.Chief Scientific Officer08/10/2017467,665
Dubensky Thomas W.Chief Scientific Officer08/11/2017101,538
ISAACS STEPHEN TPresident and CEO08/07/201718,000
ISAACS STEPHEN TPresident and CEO08/07/2017487,564
SCHAFER GREGORY WChief Operating Officer08/08/201718,004
SCHAFER GREGORY WChief Operating Officer08/07/201731,616
SCHAFER GREGORY WChief Operating Officer08/07/2017314,233
SCHAFER GREGORY WChief Operating Officer08/08/2017172,550
Brockstedt Dirk G.EVP of Research and Dev.08/07/20175,200
Brockstedt Dirk G.EVP of Research and Dev.08/07/2017121,795
Lew JenniferSr. Vice President of Finance08/07/20175,412
Lew JenniferSr. Vice President of Finance08/07/201780,290
Lew JenniferSr. Vice President of Finance07/03/20179,840
Lew JenniferSr. Vice President of Finance07/03/2017133,632
ISAACS STEPHEN TPresident and CEO07/03/201719,965
ISAACS STEPHEN TPresident and CEO07/05/201714,763
ISAACS STEPHEN TPresident and CEO07/03/2017427,634
Brockstedt Dirk G.EVP of Research and Dev.07/03/20174,826
Brockstedt Dirk G.EVP of Research and Dev.07/03/2017110,167
Dubensky Thomas W.Chief Scientific Officer07/06/20172,346
Dubensky Thomas W.Chief Scientific Officer07/05/201717,518
Dubensky Thomas W.Chief Scientific Officer07/03/20176,136
Dubensky Thomas W.Chief Scientific Officer07/06/201750,673
Dubensky Thomas W.Chief Scientific Officer07/05/2017385,936
Dubensky Thomas W.Chief Scientific Officer07/03/2017130,028
Lew JenniferSr. Vice President of Finance06/28/20179,840
Lew JenniferSr. Vice President of Finance06/28/2017134,236
SCHAFER GREGORY WChief Operating Officer06/28/201758,000
SCHAFER GREGORY WChief Operating Officer06/28/2017450,568
ISAACS STEPHEN TPresident and CEO06/19/201720,800
ISAACS STEPHEN TPresident and CEO06/19/2017420,164
Dubensky Thomas W.Chief Scientific Officer06/01/201740,545
Dubensky Thomas W.Chief Scientific Officer06/05/20179,140
Dubensky Thomas W.Chief Scientific Officer06/02/201725,352
Dubensky Thomas W.Chief Scientific Officer06/05/2017175,628
Dubensky Thomas W.Chief Scientific Officer06/02/2017492,283
Dubensky Thomas W.Chief Scientific Officer06/01/2017779,866
Brockstedt Dirk G.EVP of Research and Dev.06/01/20174,160
Brockstedt Dirk G.EVP of Research and Dev.06/01/201780,020
Brockstedt Dirk G.EVP of Research and Dev.05/17/20179,756
Templeman BlaineExecutive VP, General Counsel05/17/201715,903
ISAACS STEPHEN TPresident and CEO05/15/20175,512
ISAACS STEPHEN TPresident and CEO05/16/20178,670
ISAACS STEPHEN TPresident and CEO05/16/2017166,797
ISAACS STEPHEN TPresident and CEO05/15/2017106,154
Brockstedt Dirk G.EVP of Research and Dev.05/11/20174,160
Brockstedt Dirk G.EVP of Research and Dev.05/11/201777,725
Dubensky Thomas W.Chief Scientific Officer05/12/20172,235
Dubensky Thomas W.Chief Scientific Officer05/11/2017728
Dubensky Thomas W.Chief Scientific Officer05/12/201742,658
Dubensky Thomas W.Chief Scientific Officer05/11/201713,870
Brockstedt Dirk G.EVP of Research and Dev.04/03/20173,600
Brockstedt Dirk G.EVP of Research and Dev.04/03/201785,645
ISAACS STEPHEN TPresident and CEO04/03/201714,182
ISAACS STEPHEN TPresident and CEO04/03/2017280,429
ISAACS STEPHEN TPresident and CEO03/13/201714,182
ISAACS STEPHEN TPresident and CEO03/13/2017309,434
Brockstedt Dirk G.EVP of Research and Dev.03/09/20173,600
Brockstedt Dirk G.EVP of Research and Dev.03/09/201788,001
Dubensky Thomas W.Chief Scientific Officer03/09/201719,446
Dubensky Thomas W.Chief Scientific Officer03/09/2017274,078
Brockstedt Dirk G.EVP of Research and Dev.01/17/20173,600
Brockstedt Dirk G.EVP of Research and Dev.01/17/201794,858
Templeman BlaineExecutive VP, General Counsel01/11/201745,231
Dubensky Thomas W.Chief Scientific Officer01/03/201713,000
Dubensky Thomas W.Chief Scientific Officer01/03/2017278,990
ISAACS STEPHEN TPresident and CEO01/03/201714,182
ISAACS STEPHEN TPresident and CEO01/03/2017303,289
SCHAFER GREGORY WChief Operating Officer12/23/201628,700
ISAACS STEPHEN TPresident and CEO12/01/201614,182
ISAACS STEPHEN TPresident and CEO12/01/2016295,169
Dubensky Thomas W.Chief Scientific Officer12/01/201625,893
Dubensky Thomas W.Chief Scientific Officer12/01/2016273,500
Haghighat RossDirector11/14/2016109,864
ISAACS STEPHEN TPresident and CEO11/14/201614,182
ISAACS STEPHEN TPresident and CEO11/14/2016416,050
Lew JenniferSr. Vice President of Finance11/10/20168,946
Lew JenniferSr. Vice President of Finance11/10/2016163,104
SCHAFER GREGORY WChief Operating Officer11/11/201643,709
SCHAFER GREGORY WChief Operating Officer11/10/201672,291
SCHAFER GREGORY WChief Operating Officer11/11/2016448,033
SCHAFER GREGORY WChief Operating Officer11/10/2016734,698
Dubensky Thomas W.Chief Scientific Officer11/10/201632,588
Dubensky Thomas W.Chief Scientific Officer11/10/2016369,408
ISAACS STEPHEN TPresident and CEO10/03/201614,182
ISAACS STEPHEN TPresident and CEO10/03/2016345,522
Dubensky Thomas W.Chief Scientific Officer10/03/201627,437
Dubensky Thomas W.Chief Scientific Officer10/03/2016316,908
Lew JenniferSr. Vice President of Finance09/19/20164,473
Lew JenniferSr. Vice President of Finance09/19/201695,082
Dubensky Thomas W.Chief Scientific Officer09/01/201628,259
Dubensky Thomas W.Chief Scientific Officer09/01/2016350,775
Dubensky Thomas W.Chief Scientific Officer08/11/201624,625
Dubensky Thomas W.Chief Scientific Officer08/11/2016379,500
Dubensky Thomas W.Chief Scientific Officer07/05/201625,963
Dubensky Thomas W.Chief Scientific Officer07/05/2016290,250
Brockstedt Dirk G.Sr. VP of Research and Dev.05/16/20167,421
SCHAFER GREGORY WChief Operating Officer05/16/20167,421
Dubensky Thomas W.Chief Scientific Officer05/16/20167,421
Morningside Venture (VI) Investments Ltd10% Owner02/18/201676,097
Brockstedt Dirk G.Sr. VP of Research and Dev.01/11/201610,856
Brockstedt Dirk G.Sr. VP of Research and Dev.01/11/2016479,015
SCHAFER GREGORY WChief Operating Officer01/08/201620,000
SCHAFER GREGORY WChief Operating Officer01/08/2016471,600
Dubensky Thomas W.Chief Scientific Officer01/04/201670,158
Dubensky Thomas W.Chief Scientific Officer01/04/2016395,531
ISAACS STEPHEN TPresident and CEO01/05/20166,500
ISAACS STEPHEN TPresident and CEO01/04/20166,500
ISAACS STEPHEN TPresident and CEO01/04/2016329,603
ISAACS STEPHEN TPresident and CEO01/05/2016328,196
Lew JenniferSr. Vice President of Finance01/06/20164,298
Lew JenniferSr. Vice President of Finance01/06/2016134,765
ISAACS STEPHEN TPresident and CEO12/31/20154,500
Lew JenniferSr. Vice President of Finance12/29/20153,444
SCHAFER GREGORY WChief Operating Officer12/24/201512,300
Brockstedt Dirk G.Sr. VP of Research and Dev.12/16/201517,400
Brockstedt Dirk G.Sr. VP of Research and Dev.12/10/201536,250
Brockstedt Dirk G.Sr. VP of Research and Dev.12/10/2015745,423
SCHAFER GREGORY WChief Operating Officer12/07/201536,250
SCHAFER GREGORY WChief Operating Officer12/07/2015743,571
Lew JenniferSr. Vice President of Finance12/03/20154,298
Lew JenniferSr. Vice President of Finance12/03/2015156,486
ISAACS STEPHEN TPresident and CEO12/01/201513,000
ISAACS STEPHEN TPresident and CEO12/01/2015727,664
Dubensky Thomas W.Chief Scientific Officer12/01/201564,373
Dubensky Thomas W.Chief Scientific Officer12/01/2015878,104
Greenman William MarinerDirector11/30/201591,950
Lew JenniferSr. Vice President of Finance11/18/20154,298
Lew JenniferSr. Vice President of Finance11/18/2015191,426
ISAACS STEPHEN TPresident and CEO11/16/201513,000
ISAACS STEPHEN TPresident and CEO11/16/2015688,490
Brockstedt Dirk G.Sr. VP of Research and Dev.11/17/201513,220
Brockstedt Dirk G.Sr. VP of Research and Dev.11/16/20152,679
Brockstedt Dirk G.Sr. VP of Research and Dev.11/17/2015545,734
Brockstedt Dirk G.Sr. VP of Research and Dev.11/16/2015204,294
SCHAFER GREGORY WChief Operating Officer11/17/201522,008
SCHAFER GREGORY WChief Operating Officer11/16/201514,242
SCHAFER GREGORY WChief Operating Officer11/17/2015434,072
SCHAFER GREGORY WChief Operating Officer11/16/2015311,168
Dubensky Thomas W.Chief Scientific Officer11/16/201513,747
Dubensky Thomas W.Chief Scientific Officer11/17/201529,753
Dubensky Thomas W.Chief Scientific Officer11/16/2015301,733
Dubensky Thomas W.Chief Scientific Officer11/17/2015587,822
ISAACS STEPHEN TPresident and CEO07/24/2015609
Rogers John E. and Lois A.10% Owner04/20/2015127,500
Rogers John E. and Lois A.10% Owner04/20/2015170,000
Rogers John E. and Lois A.10% Owner04/20/20152,499,986
Morningside Venture (VI) Investments Ltd10% Owner04/20/20157,499,992
OBrien Stephanie MonaghanDirector04/20/201528,900
OBrien Stephanie MonaghanDirector04/20/201528,900
Greenman William MarinerDirector04/20/201551,000
Lew JenniferSr. Vice President of Finance04/20/201534,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR CHINOOK THERAPEUTICS INC
STOCK BUYBACKS FOR CHINOOK THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2023
03/31/2023
1.26%
1Q
06/30/2023
12/31/2022
3.35%
2Q
06/30/2023
09/30/2022
5.63%
3Q
06/30/2023
06/30/2022
15.50%
4Q
06/30/2023
03/31/2022
22.72%
5Q
06/30/2023
12/31/2021
38.37%
6Q
Load More

Period of Report: 06/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2023
1.26%
1Q
12/31/2022
3.35%
2Q
09/30/2022
5.63%
3Q
06/30/2022
15.50%
4Q
03/31/2022
22.72%
5Q
12/31/2021
38.37%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CHINOOK THERAPEUTICS INC
LOADING...